Evidence map›Paper›PMID 39830316›Full record

ArticleIJID regions2025

Excess mortality during the first 2 years of the COVID-19 pandemic (2020-2021) in the Netherlands: Overall and across demographic subgroups.

Camila Caram-Deelder, Astrid van Hylckama Vlieg, Rolf H H Groenwold, Qingui Chen, Dennis O Mook-Kanamori, Olaf M Dekkers, Eva A S Koster, Liesbeth C de Wreede, Cees van Nieuwkoop, Dimiter D Toshkov and 1 more

Abstract read
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camila Caram-DeelderDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Astrid van Hylckama VliegDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Rolf H H GroenwoldDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Qingui ChenDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Dennis O Mook-KanamoriDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Olaf M DekkersDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Eva A S KosterDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Liesbeth C de WreedeDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Cees van NieuwkoopDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
Dimiter D ToshkovFaculty of Governance and Global Affairs, Leiden University, Leiden, The Netherlands.
Frits R RosendaalDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The overall impact of the COVID-19 pandemic on mortality can be estimated by the assessment of excess deaths from all causes because the reported number of deaths due to COVID-19 do not accurately reflect the true death toll. We assessed excess mortality in 2020 and 2021 in the Netherlands. Methods: All analyses were performed on data from comprehensive nationwide registers provided by Statistics Netherlands (Centraal Bureau voor de Statistiek), including demographic characteristics and mortality. All-cause mortality incidence rates were calculated per calendar month and compared against COVID-19 infections and preventive strategies. The all-cause mortality incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) were estimated per calendar year using Poisson regression (overall and for subgroups). Results: Compared with predicted mortality based on 2019 rates, the overall excess mortality was 8.9% (IRR 1.089, 95% CI 1.081-1.097) in 2020 and 8.5% (IRR 1.085, 95% CI 1.077-1.092) in 2021. Relative excess mortality was higher for men, people with low household income, first-generation immigrants, and individuals living in extremely urbanized areas. In 2020, excess mortality was highest in age groups above 75 years (over 10%.); in 2021, it was clearly present even in the 20-39 years age group (6.6%). Conclusions: Our results quantify excess mortality during the first 2 years of the COVID-19 pandemic in the Netherlands. We show that the extent of excess mortality varies considerably across demographic groups, which may help in identifying target groups for preventive strategies during future health crises.

Indexed as

COVID-19DemographyEpidemicEpidemiologyExcess mortalityMortalityPandemicSARS-CoV-2

Identifiers

PMID39830316
PMCPMC11742297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.